Keyphrases
Vaccination
100%
Healthcare Workers
87%
Antibody Response
58%
Thyrotropin Receptor Antibody (TRAb)
58%
Graves' Disease
58%
Hypertension
47%
Serum IgE
41%
IgG Levels
41%
Indonesia
41%
Whole-cell Vaccine
40%
SARS-CoV-2 Infection
34%
East Java Indonesia
33%
Serum Levels
33%
COVID-19
32%
Food Allergy
32%
Breakthrough Infection
29%
Pneumonia Vaccination
29%
PPSV23
29%
Children's Activities
29%
Ophtalmopathy
29%
Internist
29%
Traffic Police
29%
Air Pollution Exposure
29%
Running Head
29%
Allergy Immunology
29%
Meningococcal Vaccination
29%
COVID-19 Vaccine Booster
29%
Inactivated SARS-CoV-2
29%
Antibody Titre
29%
Retrospective Cohort Study
29%
Atopy
29%
Hospital Workers
29%
Elderly Adults
29%
Immunoglobulin E
29%
Older Adults
29%
Air Pollution
29%
Pulmonary Tuberculosis
29%
Vaccination Program
29%
Respiratory Organs
29%
MRNA Vaccine
29%
Lung Physiology
29%
AIDS/HIV
29%
Response Effects
29%
Polysaccharide
29%
Rifampicin
29%
Adverse Effects
29%
Pneumonia
29%
Nutritional Status
29%
Booster Dose
29%
Stevens-Johnson Syndrome
29%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
82%
SARS Coronavirus
77%
Diseases
63%
Receptor Antibody
58%
Graves Disease
58%
Thyrotropin Receptor
58%
Virus Vaccine
47%
Coronavirinae
39%
Adverse Event
29%
COVID-19 Vaccine
29%
mRNA Vaccine
29%
Atopy
29%
Rifampicin
29%
Acquired Immune Deficiency Syndrome
29%
Stevens Johnson Syndrome
29%
Cohort Study
29%
Lung Tuberculosis
29%
Immunoglobulin E
29%
Polysaccharide
29%
Pneumococcus Polysaccharide
29%
Vaccination
29%
Messenger RNA
29%
Eye Disease
24%
Enzyme-Linked Immunosorbent Assay
24%
Diabetes Mellitus
19%
Ethambutol
14%
Retrospective Study
14%
Medical History
14%
Respiratory Tract Infection
14%
Toxic Epidermal Necrolysis
9%
Endocrine Ophthalmopathy
9%
Receptor
9%
Cross-Sectional Study
7%
Inactivated Virus Vaccine
7%
Hypertension
7%
Medicine and Dentistry
Infection
91%
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Antibody Response
58%
COVID-19
43%
Health Care
41%
Virus Vaccine
31%
Pneumococcus Polysaccharide
29%
mRNA Vaccine
29%
COVID-19 Vaccine
29%
Patient with Acquired Immune Deficiency Syndrome
29%
Retrospective Cohort Study
29%
Booster Dose
29%
Diphtheria Toxoid CRM197
29%
Immunosenescence
29%
Polysaccharide
29%
Lung Tuberculosis
29%
Rifampicin
29%
Enzyme Linked Immunosorbent Assay
29%
Stevens-Johnson Syndrome
29%
Adverse Effect
29%
Meningococcal Disease
14%
Respiratory Tract Infection
14%
Rank Sum Test
14%
Quality of Life
14%
Community Health
14%
Retrospective Study
14%
Medical History
14%
Student T Test
14%
Deterioration
14%
Immune Response
14%
Ethambutol
14%
Immune System
14%
Adverse Event
12%
Messenger RNA
12%
Acquired Immune Deficiency Syndrome
9%
Toxic Epidermal Necrolysis
9%
Diseases
9%
Diabetes Mellitus
8%
Virus Inactivation
7%
Inactivated Virus Vaccine
7%
Body Mass Index
7%
Demography
7%
Blood Pressure
7%
Medical Examination
7%
Hypertension
7%
Pressure Control
7%